Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors
-
* Corresponding author: Anne E Lykkesfeldt al@cancer.dk
Breast Cancer Research 2009, 11:R11 doi:10.1186/bcr2230
Accesses
- Last 30 days: 105 accesses
- Last 365 days: 967 accesses
- All time: 4667 accesses